NeuroSense Therapeutics Ltd. (NRSN)
$0.38+8.57%Close
SELLCRISIS · day 26
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $9M
- Avg volume
- 223.7K
- Beta
- 1.60
- P/E (TTM)
- -0.84
- Short % float
- 3.40%
- Days to cover
- 1.2
- SI change
- +0.1%
- 1W
- -15.56%
- 1M
- -42.42%
- 3M
- -50.65%
- YTD
- -51.28%
- vs SPY 1W
- -14.19%
- vs SPY 1M
- -46.16%
- vs SPY 3M
- -53.75%
- vs SPY YTD
- -63.37%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- SEERSELLSeer, Inc.RECOVERYQ -22$2.03+0.50%
- TLSABUYTiziana Life Sciences LtdRECOVERYQ 1$1.14+1.79%
- PHIOBUYPhio Pharmaceuticals Corp.RECOVERYQ 3$1.18-2.48%
- INABBUYIN8bio, Inc.RECOVERYQ -20$1.28+5.79%
- KYNBBUYKyntra Bio, Inc.RECOVERYQ -15$7.52+2.73%
- GOVXBUYGeoVax Labs, Inc.CRISISQ -19$0.65+8.33%
- ANTXBUYAN2 Therapeutics, Inc.RECOVERYQ -7$5.81+0.35%
- ENTABUYEnanta Pharmaceuticals, Inc.RECOVERYQ 13$13.47+2.59%
- PLSEBUYPulse Biosciences, Inc.BULLQ 26$50.42+5.37%
- VNRXSELLVolitionRx LimitedCRISISQ -10$0.42-4.55%
- ZCMDBUYZhongchao Inc.CRISISQ -39$0.93-3.12%
- ODTXBUYOdyssey Therapeutics, Inc.Q 80$26.39+6.97%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 0
- VALUE
- 0
- GROWTH
- 35
- GARP
- 0
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-1305.0%
REV YoY-
ROE-2175.0%
EPS YoY-
ROA-247.3%
GROSS0
OP0
NET0
[VALUATION]
P/E TTM-0.84
P/E FWD-
SECTOR PE22.60
INDUSTRY PE17.46
P/B-6.17
P/FCF-
EV/EBITDA-1.20
EV/EBIT-
PEG-
FCF YIELD-27.63%
BUYBACK0.00%
RISK
INT COV-652.1×
D/E-
ALTMAN Z-99.61
CURR RATIO0.31
ND/EBITDA-
BETA1.60
INTEREST COVERAGE < 1.5X (-652.06X)NET INCOME (TTM) < 0
